Lifecome Biochemistry Co Ltd (002868) — Capital Reinvestment Ratio

Latest as of September 2025: 0.23x

Lifecome Biochemistry Co Ltd (002868) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥13.24 Million) in capital expenditures (CN¥3.02 Million). See Lifecome Biochemistry Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.23x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥13.24 Million
CNY

Capital Expenditures

CN¥3.02 Million
CNY

Data as of

Sep 2025
Most recent filing

Lifecome Biochemistry Co Ltd Capital Reinvestment Ratio (2012–2024)

This chart tracks Lifecome Biochemistry Co Ltd's Capital Reinvestment Ratio across 11 annual periods.

Annual Capital Reinvestment Ratio for Lifecome Biochemistry Co Ltd (2012–2024)

Year-by-year Capital Reinvestment Ratio for Lifecome Biochemistry Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see Lifecome Biochemistry Co Ltd (002868) market capitalisation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.88x CN¥141.41 Million CN¥125.06 Million ▼ -91.3%
2021 10.16x CN¥35.17 Million CN¥357.17 Million ▲ +263.0%
2020 2.80x CN¥90.72 Million CN¥253.79 Million ▲ +65.0%
2019 1.70x CN¥74.09 Million CN¥125.60 Million ▲ +190.0%
2018 0.58x CN¥83.70 Million CN¥48.93 Million ▲ +202.7%
2017 0.19x CN¥96.11 Million CN¥18.56 Million ▲ +76.5%
2016 0.11x CN¥135.41 Million CN¥14.82 Million ▼ -64.9%
2015 0.31x CN¥127.11 Million CN¥39.65 Million ▼ -20.6%
2014 0.39x CN¥62.76 Million CN¥24.66 Million ▼ -46.4%
2013 0.73x CN¥77.68 Million CN¥57.00 Million ▼ -9.2%
2012 0.81x CN¥60.92 Million CN¥49.25 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow